, Cystic Fibrosis Foundation, 2017.

J. S. Elborn, Cystic fibrosis, Lancet, vol.388, pp.2519-2531, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01685293

J. R. Riordan, Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA, Science, vol.245, issue.4922, pp.1066-1073, 1989.

H. J. Fuchs, Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group, N Engl J Med, vol.331, issue.10, pp.637-642, 1994.

B. W. Ramsey, A CFTR potentiator in patients with cystic fibrosis and the G551D mutation, N Engl J Med, vol.365, issue.18, pp.1663-1672, 2011.

C. E. Wainwright, Lumacaftor-ivacaftor in patients with cystic fibrosis homozygous for Phe508del CFTR, N Engl J Med, vol.373, issue.3, pp.220-231, 2015.

J. L. Taylor-cousar, Tezacaftor-ivacaftor in patients with cystic fibrosis homozygous for Phe508del, N Engl J Med, vol.377, issue.21, pp.2013-2023, 2017.

S. M. Rowe, Tezacaftor-ivacaftor in residualfunction heterozygotes with cystic fibrosis, N Engl J Med, vol.377, issue.21, pp.2024-2035, 2017.

M. N. Hurley, T. M. Mckeever, A. P. Prayle, A. W. Fogarty, and A. R. Smyth, Rate of improvement of CF life expectancy exceeds that of general population--observational death registration study, J Cyst Fibros, vol.13, issue.4, pp.410-415, 2014.

H. Matsui, Evidence for periciliary liquid layer depletion, not abnormal ion composition, in the pathogenesis of cystic fibrosis airways disease, Cell, vol.95, issue.7, pp.1005-1015, 1998.

P. D. Sly, Risk factors for bronchiectasis in children with cystic fibrosis, N Engl J Med, vol.368, issue.21, pp.1963-1970, 2013.

B. H. Rosen, Infection is not required for mucoinflammatory lung disease in CFTR-knockout ferrets, Am J Respir Crit Care Med, vol.197, issue.10, pp.1308-1318, 2018.

N. W. Keiser, Defective innate immunity and hyperinflammation in newborn cystic fibrosis transmembrane conductance regulator-knockout ferret lungs, Am J Respir Cell Mol Biol, vol.52, issue.6, pp.683-694, 2015.

C. S. Rogers, Disruption of the CFTR gene produces a model of cystic fibrosis in newborn pigs, Science, vol.321, issue.5897, pp.1837-1841, 2008.

D. A. Stoltz, Cystic fibrosis pigs develop lung disease and exhibit defective bacterial eradication at birth, Sci Transl Med, vol.2, issue.29, pp.29-31, 2010.

X. Su, M. R. Looney, H. E. Su, J. W. Lee, Y. Song et al., Role of CFTR expressed by neutrophils in modulating acute lung inflammation and injury in mice, Inflamm Res, vol.60, issue.7, pp.619-632, 2011.

E. M. Bruscia, Macrophages directly contribute to the exaggerated inflammatory response in cystic fibrosis transmembrane conductance regulator-/-mice, Am J Respir Cell Mol Biol, vol.40, issue.3, pp.295-304, 2009.

R. G. Painter, L. Marrero, G. A. Lombard, V. G. Valentine, W. M. Nauseef et al., CFTR-mediated halide transport in phagosomes of human neutrophils, J Leukoc Biol, vol.87, issue.5, pp.933-942, 2010.

R. G. Painter, CFTR Expression in human neutrophils and the phagolysosomal chlorination defect in cystic fibrosis, Biochemistry, vol.45, issue.34, pp.10260-10269, 2006.

A. Di, CFTR regulates phagosome acidification in macrophages and alters bactericidal activity, Nat Cell Biol, vol.8, issue.9, pp.933-944, 2006.

D. Mattoscio, Cystic fibrosis transmembrane conductance regulator (CFTR) expression in human platelets: impact on mediators and mechanisms of the inflammatory response, FASEB J, vol.24, issue.10, pp.3970-3980, 2010.

E. M. Bruscia, Abnormal trafficking and degradation of TLR4 underlie the elevated inflammatory response in cystic fibrosis, J Immunol, vol.186, issue.12, pp.6990-6998, 2011.

C. Deppermann and P. Kubes, Start a fire, kill the bug: The role of platelets in inflammation and infection, Innate Immun, vol.24, issue.6, pp.335-348, 2018.

M. R. Looney, J. X. Nguyen, Y. Hu, J. A. Van-ziffle, C. A. Lowell et al., Platelet depletion and aspirin treatment protect mice in a two-event model of transfusion-related acute lung injury, J Clin Invest, vol.119, issue.11, pp.3450-3461, 2009.

G. Ortiz-muñoz, B. Mallavia, A. Bins, M. Headley, M. F. Krummel et al., Aspirin-triggered 15-epi-lipoxin A4 regulates neutrophil-platelet aggregation and attenuates acute lung injury in mice, Blood, vol.124, issue.17, pp.2625-2634, 2014.

J. Rossaint, Directed transport of neutrophil-derived extracellular vesicles enables platelet-mediated innate immune response, Nat Commun, vol.7, p.13464, 2016.

W. Bain, Platelets inhibit apoptotic lung epithelial cell death and protect mice against infection-induced lung injury, Blood Adv, vol.3, issue.3, pp.432-445, 2019.

R. T. Amison, Platelet depletion impairs host defense to pulmonary infection with pseudomonas aeruginosa in mice, Am J Respir Cell Mol Biol, vol.58, issue.3, pp.331-340, 2018.

M. Mp, Chloride channels in human platelets: evidence for activation by internal calcium, J Membr Biol, vol.118, issue.1, pp.69-75, 1990.

B. P. O'sullivan, Platelet activation in cystic fibrosis, Blood, vol.105, issue.12, pp.4635-4641, 2005.

M. W. Konstan, P. J. Byard, C. L. Hoppel, and P. B. Davis, Effect of high-dose ibuprofen in patients with cystic fibrosis, N Engl J Med, vol.332, issue.13, pp.848-854, 1995.

J. F. Markworth, Human inflammatory and resolving lipid mediator responses to resistance exercise and ibuprofen treatment, Am J Physiol Regul Integr Comp Physiol, vol.305, issue.11, pp.1281-1296, 2013.

C. Zhao, Important role of platelets in modulating endotoxin-induced lung inflammation in CFTR-deficient mice, PLoS ONE, vol.8, issue.12, p.82683, 2013.

F. Antigny, Transient receptor potential canonical channel 6 links Ca2+ mishandling to cystic fibrosis transmembrane conductance regulator channel dysfunction in cystic fibrosis, Am J Respir Cell Mol Biol, vol.44, issue.1, pp.83-90, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00559252

L. Albarran, TRPC6 participates in the regulation of cytosolic basal calcium concentration in murine resting platelets, Biochim Biophys Acta, vol.1843, issue.4, pp.789-796, 2014.

H. P. Vemana, Z. A. Karim, C. Conlon, and F. T. Khasawneh, A critical role for the transient receptor potential channel type 6 in human platelet activation, PLoS ONE, vol.10, issue.4, p.125764, 2015.

S. R. Clark, Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood, Nat Med, vol.13, issue.4, pp.463-469, 2007.

A. Caudrillier, Platelets induce neutrophil extracellular traps in transfusion-related acute lung injury, J Clin Invest, vol.122, issue.7, pp.2661-2671, 2012.

B. F. Kraemer, Novel anti-bacterial activities of ?-defensin 1 in human platelets: suppression of pathogen growth and signaling of neutrophil extracellular trap formation, PLoS Pathog, vol.7, issue.11, p.1002355, 2011.

C. A. Hodges, C. U. Cotton, M. R. Palmert, and M. L. Drumm, Generation of a conditional null allele for Cftr in mice, Genesis, vol.46, issue.10, pp.546-552, 2008.

R. Tiedt, T. Schomber, H. Hao-shen, and R. C. Skoda, Pf4-Cre transgenic mice allow the generation of lineage-restricted gene knockouts for studying megakaryocyte and platelet function in vivo, Blood, vol.109, issue.4, pp.1503-1506, 2007.

B. E. Clausen, C. Burkhardt, W. Reith, R. Renkawitz, and I. Förster, Conditional gene targeting in macrophages and granulocytes using LysMcre mice, Transgenic Res, vol.8, issue.4, pp.265-277, 1999.

E. Passegué, E. F. Wagner, and I. L. Weissman, JunB deficiency leads to a myeloproliferative disorder arising from hematopoietic stem cells, Cell, vol.119, issue.3, pp.431-443, 2004.

T. Ma, Thiazolidinone CFTR inhibitor identified by high-throughput screening blocks cholera toxin-induced intestinal fluid secretion, J Clin Invest, vol.110, issue.11, pp.1651-1658, 2002.

D. S. Snyder, L. Tradtrantip, C. Yao, M. J. Kurth, and A. S. Verkman, Potent, metabolically stable benzopyrimido-pyrrolo-oxazine-dione (BPO) CFTR inhibitors for polycystic kidney disease, J Med Chem, vol.54, issue.15, pp.5468-5477, 2011.

S. R. Hassock, M. X. Zhu, C. Trost, V. Flockerzi, and K. S. Authi, Expression and role of TRPC proteins in human platelets: evidence that TRPC6 forms the store-independent calcium entry channel, Blood, vol.100, issue.8, pp.2801-2811, 2002.

D. Varga-szabo, Store-operated Ca(2+) entry in platelets occurs independently of transient receptor potential (TRP) C1, Pflugers Arch, vol.457, issue.2, pp.377-387, 2008.

A. Singh, M. E. Hildebrand, E. Garcia, and T. P. Snutch, The transient receptor potential channel antagonist SKF96365 is a potent blocker of low-voltage-activated T-type calcium channels

, Br J Pharmacol, vol.160, issue.6, pp.1464-1475, 2010.

R. D. Gray, Delayed neutrophil apoptosis enhances NET formation in cystic fibrosis, Thorax, vol.73, issue.2, pp.134-144, 2018.

B. P. O'sullivan and A. D. Michelson, The inflammatory role of platelets in cystic fibrosis, Am J Respir Crit Care Med, vol.173, issue.5, pp.483-490, 2006.

S. Feske, H. Wulff, and E. Y. Skolnik, Ion channels in innate and adaptive immunity, Annu Rev Immunol, vol.33, pp.291-353, 2015.

L. Vachel, C. Norez, F. Becq, and C. Vandebrouck, Effect of VX-770 (ivacaftor) and OAG on Ca2+ influx and CFTR activity in G551D and F508del-CFTR expressing cells, J Cyst Fibros, vol.12, issue.6, pp.584-591, 2013.
URL : https://hal.archives-ouvertes.fr/hal-00990531

M. W. Konstan, M. D. Schluchter, W. Xue, and P. B. Davis, Clinical use of ibuprofen is associated with slower FEV1 decline in children with cystic fibrosis, Am J Respir Crit Care Med, vol.176, issue.11, pp.1084-1089, 2007.

M. Tauseef, TLR4 activation of TRPC6-dependent calcium signaling mediates endotoxininduced lung vascular permeability and inflammation, J Exp Med, vol.209, issue.11, pp.1953-1968, 2012.

E. W. Weber, F. Han, M. Tauseef, L. Birnbaumer, D. Mehta et al., TRPC6 is the endothelial calcium channel that regulates leukocyte transendothelial migration during the inflammatory response, J Exp Med, vol.212, issue.11, pp.1883-1899, 2015.

L. Zhou, C. R. Dey, S. E. Wert, M. D. Duvall, R. A. Frizzell et al., Correction of lethal intestinal defect model of cystic fibrosis by human CFTR, Science, vol.266, issue.5191, pp.1705-1708, 1994.

P. Espinosa, E. V. Murad, J. P. Ting, and H. J. , Khasawneh FT. Mouse transient receptor potential channel 6: role in hemostasis and thrombogenesis, Biochem Biophys Res Commun, vol.417, issue.2, pp.853-856, 2012.

J. A. Van-ziffle and C. A. Lowell, Neutrophil-specific deletion of Syk kinase results in reduced host defense to bacterial infection, Blood, vol.114, issue.23, pp.4871-4882, 2009.

E. Lefrançais, B. Mallavia, H. Zhuo, C. S. Calfee, and M. R. Looney, Maladaptive role of neutrophil extracellular traps in pathogen-induced lung injury, JCI Insight, vol.3, issue.3, p.98178, 2018.

G. Ortiz-muñoz and M. R. Looney, Non-invasive intratracheal instillation in mice, Bio Protoc, vol.5, issue.12, p.1504, 2015.

C. S. Tran, The pseudomonas aeruginosa type III translocon is required for biofilm formation at the epithelial barrier, PLoS Pathog, vol.10, issue.11, p.1004479, 2014.

C. Valet, Essential role of class II PI3K-C2? in platelet membrane morphology, Blood, vol.126, issue.9, pp.1128-1137, 2015.

E. Lefrançais, The lung is a site of platelet biogenesis and a reservoir for haematopoietic progenitors, Nature, vol.544, issue.7648, pp.105-109, 2017.

L. A. Krueger, M. R. Barnard, A. L. Frelinger, M. I. Furman, and A. D. Michelson, Immunophenotypic analysis of platelets, Curr Protoc Cytom, 2002.

L. K. Jennings, M. E. Dockter, C. D. Wall, C. F. Fox, and D. M. Kennedy, Calcium mobilization in human platelets using indo-1 and flow cytometry, Blood, vol.74, issue.8, pp.2674-2680, 1989.

C. Valet, A dual role for the class III PI3K, Vps34, in platelet production and thrombus growth, Blood, vol.130, issue.18, pp.2032-2042, 2017.
URL : https://hal.archives-ouvertes.fr/hal-02411957